1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31

• CAT Number: S000222
• CAS Number: 179093-76-6
• Molecular Formula: C42H51D31NO8P
• Molecular Weight: 791.27
• Purity: ≥95%
• IUPAC Name: [(2R)-3-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-hentriacontadeuteriohexadecanoyloxy)-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
• InChI: InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20-/t40-/m1/s1/i2D3,7D2,9D2,11D2,13D2,15D2,17D2,19D2,22D2,24D2,26D2,28D2,30D2,32D2,34D2
• InChIKey: WTJKGGKOPKCXLL-KHCKXXADSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC

1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 (CAS: 179093-76-6), a premium pharmaceutical research compound designed for advanced lipidomics and membrane biology studies. As a deuterated analog of 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), it offers enhanced stability and improved isotopic tracking. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies and research in lipid metabolism and membrane dynamics. Trusted by leading laboratories, 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 is your go-to solution for cutting-edge lipidomics research. Unlock new possibilities in lipid and membrane studies with 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31, where innovation meets reliability.

Reference

[1]. Moreno MJ, et al. Translocation of phospholipids and dithionite permeability in liquid-ordered and liquid-disordered membranes. Biophys J. 2006 Aug 1;91(3):873-81.
[Content Brief]

[2]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.
[Content Brief]